Matches in Wikidata for { <http://www.wikidata.org/entity/Q92603682> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q92603682 description "article scientifique publié en 2020" @default.
- Q92603682 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q92603682 description "scientific article published on 09 March 2020" @default.
- Q92603682 description "wetenschappelijk artikel" @default.
- Q92603682 description "наукова стаття, опублікована 9 березня 2020" @default.
- Q92603682 name "Predictors of Discontinuation of Efavirenz as Treatment for HIV, Due to Neuropsychiatric Side Effects, in a Multi-Ethnic Sample in the United Kingdom" @default.
- Q92603682 name "Predictors of Discontinuation of Efavirenz as Treatment for HIV, Due to Neuropsychiatric Side Effects, in a Multi-Ethnic Sample in the United Kingdom" @default.
- Q92603682 type Item @default.
- Q92603682 label "Predictors of Discontinuation of Efavirenz as Treatment for HIV, Due to Neuropsychiatric Side Effects, in a Multi-Ethnic Sample in the United Kingdom" @default.
- Q92603682 label "Predictors of Discontinuation of Efavirenz as Treatment for HIV, Due to Neuropsychiatric Side Effects, in a Multi-Ethnic Sample in the United Kingdom" @default.
- Q92603682 prefLabel "Predictors of Discontinuation of Efavirenz as Treatment for HIV, Due to Neuropsychiatric Side Effects, in a Multi-Ethnic Sample in the United Kingdom" @default.
- Q92603682 prefLabel "Predictors of Discontinuation of Efavirenz as Treatment for HIV, Due to Neuropsychiatric Side Effects, in a Multi-Ethnic Sample in the United Kingdom" @default.
- Q92603682 P1433 Q92603682-D51D0313-DFBA-4741-9661-13546D39164B @default.
- Q92603682 P1476 Q92603682-F587AE11-7C01-4445-8A68-66BC83B97B2B @default.
- Q92603682 P2093 Q92603682-7ADD55A0-39EB-4EFC-93D0-B68FC7847DE2 @default.
- Q92603682 P2093 Q92603682-831C1710-4431-484C-A035-1D552A95C231 @default.
- Q92603682 P31 Q92603682-D7472353-40D8-4E60-8CAA-A65C62ECA705 @default.
- Q92603682 P356 Q92603682-AFAEA17F-07E3-4F99-8664-3BF9543A10A3 @default.
- Q92603682 P50 Q92603682-D60D9A53-279C-459F-9254-42142B6C1AA0 @default.
- Q92603682 P577 Q92603682-CD634F56-01FE-4EC4-8297-327C8C9FBFCB @default.
- Q92603682 P698 Q92603682-8F4617E8-C402-4549-B865-D75C62CD8004 @default.
- Q92603682 P921 Q92603682-004303C8-C840-40EF-BAF7-5110663DA874 @default.
- Q92603682 P921 Q92603682-069ACA36-13D4-4447-86A3-F14BC3D7F6B5 @default.
- Q92603682 P921 Q92603682-9F0E94FE-5619-4DEC-AF56-368E9845B10A @default.
- Q92603682 P356 AID.2019.0193 @default.
- Q92603682 P698 31931589 @default.
- Q92603682 P1433 Q4651880 @default.
- Q92603682 P1476 "Predictors of Discontinuation of Efavirenz as Treatment for HIV, Due to Neuropsychiatric Side Effects, in a Multi-Ethnic Sample in the United Kingdom" @default.
- Q92603682 P2093 "Johnson Kai Chun Law" @default.
- Q92603682 P2093 "Laurie T Butler" @default.
- Q92603682 P31 Q13442814 @default.
- Q92603682 P356 "10.1089/AID.2019.0193" @default.
- Q92603682 P50 Q82687586 @default.
- Q92603682 P577 "2020-03-09T00:00:00Z" @default.
- Q92603682 P698 "31931589" @default.
- Q92603682 P921 Q111242702 @default.
- Q92603682 P921 Q145 @default.
- Q92603682 P921 Q422645 @default.